Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of eletriptan binding at human 5-HT1B and 5-HT1D receptors

This publication has 35 references indexed in Scilit:

• G‐protein activation at 5‐HT_1A receptors by the 5‐ht_1F ligand LY334370 in guinea‐pig brain sections and recombinant cell lines
  British Journal of Pharmacology, 1998
• Pharmacological analysis of the haemodynamic effects of 5-HT_1B/Dreceptor agonists in the normotensive rat
  British Journal of Pharmacology, 1998
• Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine
  Life Sciences, 1997
• Recombinant saphenous vein 5‐HT_1Breceptors of the rabbit: comparative pharmacology with human 5‐HT_1Breceptors
  British Journal of Pharmacology, 1997
• Monthly Update: Central & Peripheral Nervous Systems: Pharmacology of antimigraine 5-HT_1Dreceptor agonists
  Expert Opinion on Investigational Drugs, 1996
• Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• A comparison of the contractile effects of 5‐hydroxytryptamine, sumatriptan and MK‐462 on human coronary artery in vitro.
  British Journal of Clinical Pharmacology, 1995
• Expression of serotonin receptor mRNAs in blood vessels
  FEBS Letters, 1995
• Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties
  Life Sciences, 1981
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973